Aptose Biosciences Reports Results for the Third Quarter Ended September 30, 2015
SAN DIEGO and TORONTO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today reported …